Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 14 studies | 46% ± 19% | |
microglial cell | 9 studies | 26% ± 7% | |
glutamatergic neuron | 8 studies | 43% ± 20% | |
retinal ganglion cell | 7 studies | 64% ± 19% | |
type II pneumocyte | 7 studies | 56% ± 20% | |
GABAergic neuron | 6 studies | 32% ± 14% | |
endothelial cell | 3 studies | 34% ± 14% | |
macrophage | 3 studies | 37% ± 3% | |
neuron | 3 studies | 54% ± 20% | |
granule cell | 3 studies | 42% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1602.23 | 328 / 328 | 95% | 10.20 | 169 / 178 |
brain | 99% | 1438.32 | 2610 / 2642 | 94% | 16.96 | 663 / 705 |
lung | 75% | 897.87 | 434 / 578 | 71% | 10.04 | 824 / 1155 |
adrenal gland | 100% | 811.16 | 257 / 258 | 39% | 3.70 | 89 / 230 |
kidney | 45% | 112.00 | 40 / 89 | 61% | 5.37 | 546 / 901 |
thymus | 32% | 66.74 | 207 / 653 | 73% | 15.84 | 443 / 605 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.42 | 1 / 1 |
lymph node | 0% | 0 | 0 / 0 | 90% | 10.31 | 26 / 29 |
stomach | 51% | 181.27 | 183 / 359 | 32% | 1.98 | 92 / 286 |
spleen | 83% | 211.29 | 200 / 241 | 0% | 0 | 0 / 0 |
bladder | 38% | 130.24 | 8 / 21 | 44% | 5.00 | 221 / 504 |
breast | 44% | 112.32 | 204 / 459 | 17% | 0.84 | 188 / 1118 |
ovary | 23% | 44.63 | 41 / 180 | 30% | 1.38 | 130 / 430 |
esophagus | 7% | 10.54 | 98 / 1445 | 40% | 2.48 | 73 / 183 |
adipose | 46% | 100.56 | 548 / 1204 | 0% | 0 | 0 / 0 |
intestine | 23% | 53.88 | 224 / 966 | 21% | 1.66 | 111 / 527 |
skin | 1% | 1.34 | 14 / 1809 | 37% | 12.23 | 176 / 472 |
heart | 36% | 128.98 | 313 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 31% | 1.42 | 14 / 45 |
liver | 7% | 12.60 | 16 / 226 | 17% | 2.21 | 70 / 406 |
uterus | 5% | 9.26 | 8 / 170 | 15% | 1.15 | 71 / 459 |
peripheral blood | 7% | 22.60 | 63 / 929 | 0% | 0 | 0 / 0 |
prostate | 4% | 7.15 | 10 / 245 | 1% | 0.04 | 5 / 502 |
blood vessel | 4% | 6.99 | 47 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.06 | 1 / 80 |
muscle | 0% | 0.17 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0140882 | Biological process | zinc export across plasma membrane |
GO_0099180 | Biological process | zinc ion import into synaptic vesicle |
GO_0042552 | Biological process | myelination |
GO_0031901 | Cellular component | early endosome membrane |
GO_0030672 | Cellular component | synaptic vesicle membrane |
GO_0031902 | Cellular component | late endosome membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | TMEM163 |
Protein name | Transmembrane protein 163 |
Synonyms | |
Description | FUNCTION: Zinc ion transporter that mediates zinc efflux and plays a crucial role in intracellular zinc homeostasis . Binds the divalent cations Zn(2+), Ni(2+), and to a minor extent Cu(2+) (By similarity). Is a functional modulator of P2X purinoceptors, including P2RX1, P2RX3, P2RX4 and P2RX7 . Plays a role in central nervous system development and is required for myelination, and survival and proliferation of oligodendrocytes . . |
Accessions | Q8TC26 ENST00000281924.6 [Q8TC26-1] |